Delta-like SARS-CoV-2 variants with enhanced transmissibility may cause a more severe pandemic

A SARS-CoV-2 variant with traits similar to that of the Delta variant-;enhanced transmissibility and an ability to infect people who had previous infections/vaccination-;will cause a more severe pandemic with more infections and breakthrough infections/reinfections than variants with either trait alone, according to a mathematical model created by researchers at Harvard T.H. Chan School of Public Health.

Their work, which was published online November 19, 2021 in Cell, could help researchers and public health officials interpret the significance of novel and existing variants and design tailored public health responses for various scenarios based on a variant's characteristics.

Thus far, evidence of immune escape-;the ability of a variant to evade the immune system and cause reinfections or breakthrough infections-;has been a red flag. Our findings say it's maybe more of a yellow flag-;this is not such a big deal on its own. But when it's combined with enhanced transmissibility, then it can be a really big deal."

Mary Bushman, co-author of the Cell paper and postdoctoral research fellow in the Department of Epidemiology at Harvard Chan School

As the COVID pandemic has progressed, variants of the initial wild-type SARS-CoV-2 virus have emerged. Some have quickly become a dominant strain and increased the number of infections, like the Alpha and Delta variants, while others, like Beta, failed to take hold or significantly affect the pandemic's trajectory. To understand the effects that certain factors would have on a pandemic, Bushman created a model that simulates how pandemics fueled by hypothetical variants would affect populations that are using various combinations of masking with physical distancing, and vaccinations.

The analysis simulated a SARS-CoV-2 pandemic with several different hypothetical variants including combinations of the two traits: enhanced transmissibility, similar to the Alpha variant; partial immune escape, similar to the Beta variant; enhanced transmissibility with partial immune escape, similar to the Delta variant; and a variant with neither trait. The analysis also factored in how certain variables, such as masking/physical distancing or vaccinations, would affect the pandemic's trajectory. For each of the scenarios, the researchers analyzed the total number of infections as well as the number/percentage of infections averted by vaccination.

Bushman and their team determined that a variant with enhanced transmissibility alone would likely be more dangerous than a variant that could partially evade the immune system. Yet a variant with both traits could cause more infections, reinfections, and breakthrough infections than a variant with either trait alone.

According to the model, vaccination is also predicted to be highly beneficial in the case of Delta-like variants because vaccinations would prevent a greater number of cases that a more transmissible virus would potentially cause, and because the milder nature of breakthrough infections should substantially reduce overall mortality.

"It's really important that people realize the emergence of variants like Delta make high levels of vaccination all the more crucial," said Bill Hanage, associate professor of epidemiology and co-author of the Cell paper. "Even if we cannot eliminate the virus, we can ensure that people face it with the best preparation, and a more transmissible virus means there will be more infections in the absence of vaccination, so more people stand to benefit from it."

Source:
Journal reference:

Bushman, M., et al. (2021) Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape. Cell. doi.org/10.1016/j.cell.2021.11.026.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals how COVID-19 affected the spread and evolution of seasonal influenza